Too Much Uncertainty, Not Enough Progress
You’re not alone. Biotech teams often tell me:
“We have too many CROs and not enough clarity.”
“We don’t know what matters most right now.”
“We’re running experiments before aligning on strategy.”
That's where I come in.

How I Help Biotechs Accelerate GPCR Discovery with Clarity, Speed & Confidence

Decisions, Not More Data
We'll define what matters, when to decide, and how to act—based on your biology, not just what's easy to test.
-
Prioritize assays based on project phase and decision points
-
Map go/no-go logic that guides program momentum
-
Focus resources where they’ll change outcomes

No More Strategy Swirl
I build structure that sticks—from CRO engagement to assay cascades—so your team isn't guessing what's next.
-
Build experiment timelines aligned with strategy, not spreadsheets
-
Set up clear deliverables across internal and CRO teams
-
Keep cross-functional teams moving with shared structure

Impress Your Board and Your Team
Walk into every update with a confident story, backed by data, decisions, and momentum.
-
Distill discovery progress into board-ready insights
-
Craft milestone updates that tie data to strategy
-
Present clear next steps that build investor confidence
Trusted by Biotech Innovators
Before working with Yamina, we were navigating challenging decisions around corporate and early discovery strategy. After bringing her in, we made confident progress on a key program and gained clarity around where to focus next. She helped bring teams together and created momentum across both science and execution.
- Murat Tunabolyu, CEO Antiverse
Ready to collaborate?
Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech, VC, and CRO teams.
©2023-2025 All rights reserved by FindYooour, LLC & Dr. GPCR Corp
Proudly created with Wix.com